www.fdanews.com/articles/101105-novartis-and-speedel-at-loggerheads-over-tekturna-royalties
Novartis and Speedel at Loggerheads Over Tekturna Royalties
November 15, 2007
Speedel has had a major falling-out with its fellow Swiss — but much bigger — partner Novartis over monies that the former believes it is owed relating to the new antihypertensive Tekturna/Rasilez.
Pharma Times